| Psoriasis |
1 |
0.99 |
| Clinical Research |
0 |
0.51 |
| Plaque Psoriasis |
0 |
0.51 |
| Healthcare and Medical Technology |
0 |
0.45 |
| Food and Drug Administration (FDA) |
0 |
0.34 |
| Steroids |
0 |
0.34 |
| Dermatitis |
0 |
0.26 |
| Anus |
0 |
0.17 |
| Cervical Region |
0 |
0.17 |
| Contact Dermatitis |
0 |
0.17 |
| Face |
0 |
0.17 |
| Folliculitis |
0 |
0.17 |
| Nasopharyngitis |
0 |
0.17 |
| Receptors |
0 |
0.17 |
| Severity Index |
0 |
0.17 |
| Topical Medication |
0 |
0.17 |
| Headache |
0 |
0.15 |
| Otolaryngology |
0 |
0.15 |
| Skin and Soft Tissue Infection |
0 |
0.15 |